ATE271614T1 - Quinone-derivate zur verbesserung der zellulare bioenergie - Google Patents
Quinone-derivate zur verbesserung der zellulare bioenergieInfo
- Publication number
- ATE271614T1 ATE271614T1 AT93909698T AT93909698T ATE271614T1 AT E271614 T1 ATE271614 T1 AT E271614T1 AT 93909698 T AT93909698 T AT 93909698T AT 93909698 T AT93909698 T AT 93909698T AT E271614 T1 ATE271614 T1 AT E271614T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- animal
- present
- sec
- therapeutic compositions
- Prior art date
Links
- 230000001413 cellular effect Effects 0.000 title abstract 4
- 150000004059 quinone derivatives Chemical class 0.000 title 1
- 230000002407 ATP formation Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 102000004316 Oxidoreductases Human genes 0.000 abstract 1
- 108090000854 Oxidoreductases Proteins 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/02—Quinones with monocyclic quinoid structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/02—Quinones with monocyclic quinoid structure
- C07C50/06—Quinones with monocyclic quinoid structure with unsaturation outside the quinoid structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPL264192 | 1992-05-28 | ||
| AUPL264292 | 1992-05-28 | ||
| PCT/AU1993/000251 WO1993024650A1 (en) | 1992-05-28 | 1993-05-28 | Therapeutic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE271614T1 true ATE271614T1 (de) | 2004-08-15 |
Family
ID=25644259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93909698T ATE271614T1 (de) | 1992-05-28 | 1993-05-28 | Quinone-derivate zur verbesserung der zellulare bioenergie |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5981601A (de) |
| EP (1) | EP0643775B1 (de) |
| JP (1) | JP3859699B2 (de) |
| AT (1) | ATE271614T1 (de) |
| AU (1) | AU666372B2 (de) |
| DE (1) | DE69333575T2 (de) |
| DK (1) | DK0643775T3 (de) |
| ES (1) | ES2224098T3 (de) |
| PT (1) | PT643775E (de) |
| WO (1) | WO1993024650A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9626177D0 (en) * | 1996-12-17 | 1997-02-05 | Univ Aberdeen | Channel mediating substrates |
| US6670127B2 (en) | 1997-09-16 | 2003-12-30 | Egea Biosciences, Inc. | Method for assembly of a polynucleotide encoding a target polypeptide |
| PT1015576E (pt) * | 1997-09-16 | 2005-09-30 | Egea Biosciences Llc | Metodo para a sintese quimica completa e montagem de genes e de genomas |
| US6472378B2 (en) * | 1998-08-31 | 2002-10-29 | Pro-Neuron, Inc. | Compositions and methods for treatment of mitochondrial diseases |
| US7915233B1 (en) | 1998-08-31 | 2011-03-29 | Wellstat Therapeutics Corporation | Compositions and methods for treatment of mitochondrial diseases |
| US7807654B2 (en) * | 1998-08-31 | 2010-10-05 | Wellstat Therapeutics Corporation | Compositions and methods for treatment of mitochondrial diseases |
| US20050019268A1 (en) * | 1999-02-11 | 2005-01-27 | Mse Pharmazeutika Gmbh | Spray containing ubiquinone Qn |
| EP1808177B1 (de) | 1999-02-23 | 2018-08-08 | The Regents of The University of California | Behandlungsmethoden für mitochondriale Erkrankungen |
| US20040224920A1 (en) * | 1999-02-23 | 2004-11-11 | The Regents Of The University Of California | Methods of treatment of mitochondrial disorders |
| AUPR177300A0 (en) * | 2000-11-29 | 2000-12-21 | Centre For Molecular Biology And Medicine | Therapeutic methods |
| EP1385950B1 (de) * | 2001-01-19 | 2008-07-02 | Centocor, Inc. | Computer vermitteltes assembly von polynucleotiden kodierend für ein zielgerichtetes polypeptide |
| US7629329B2 (en) * | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
| US20040204500A1 (en) * | 2001-06-28 | 2004-10-14 | Yasuo Sugiyama | Preventives/remedies for organ functional disorders and organ dysfunction |
| TW200304372A (en) * | 2002-03-20 | 2003-10-01 | Kanegafuchi Chemical Ind | Compositions for diabetes |
| WO2003083689A1 (en) * | 2002-03-25 | 2003-10-09 | Myriagon Corporation | Information management system |
| EP1594456B1 (de) * | 2003-01-20 | 2008-09-03 | Auriga International S.A. | Verwendung einer zusammensetzung mit vitamin k1-oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern |
| ES2619303T3 (es) | 2005-06-01 | 2017-06-26 | Edison Pharmaceuticals, Inc. | Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos |
| SI1933821T1 (sl) * | 2005-09-15 | 2020-11-30 | Ptc Therapeutics, Inc. | Repne variante redoks-aktivnih terapevtikov za zdravljenje mitohondrijskih bolezni in drugih bolezni ter modulacijo energijskih biooznačevalcev |
| WO2007100652A2 (en) | 2006-02-22 | 2007-09-07 | Edison Pharmaceuticals, Inc. | Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| EP2262519A4 (de) * | 2008-03-05 | 2011-03-23 | Edison Pharmaceuticals Inc | Behandlung von gehör- und gleichgewichtsstörungen mit redoxaktiven therapeutika |
| MX363223B (es) | 2008-09-10 | 2019-03-15 | Bioelectron Tech Corp | Tratamiento de trastornos generalizados del desarrollo con terapeuticos con actividad redox. |
| KR100977638B1 (ko) * | 2009-06-29 | 2010-08-24 | 서울대학교산학협력단 | 독성분이 있는 배출가스 혼합체에 생존하면서 온실가스를 흡수한 수생식물의 포식자를 이용하는 온실가스 제거 및 바이오 에너지 제조 방법 |
| KR101636946B1 (ko) * | 2013-07-29 | 2016-07-06 | 한국생명공학연구원 | 오로트산을 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물 |
| US10703701B2 (en) | 2015-12-17 | 2020-07-07 | Ptc Therapeutics, Inc. | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
| WO2018218287A1 (en) * | 2017-05-29 | 2018-12-06 | Woodlinda Pty Ltd | Treatment and/or prevention of neuropathic symptoms associated with diabetes mellitus type ii |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3705239A (en) * | 1970-10-16 | 1972-12-05 | Roy B Gregory | Pain removing compositions and methods |
| JPS5697223A (en) * | 1979-12-30 | 1981-08-05 | Takeda Chem Ind Ltd | Tissue metabolism activator |
| CH655005A5 (it) * | 1983-02-16 | 1986-03-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare. |
| JPS59163316A (ja) * | 1983-03-08 | 1984-09-14 | Eisai Co Ltd | けいれんの治療・予防剤 |
| JPS60100517A (ja) * | 1983-11-08 | 1985-06-04 | Eisai Co Ltd | 放射線潰瘍治療剤および方法 |
| IL78611A0 (en) * | 1986-04-23 | 1986-08-31 | Yeda Res & Dev | Production of polyprenoid and ubiquinone-type compounds |
| US5227405A (en) * | 1987-03-31 | 1993-07-13 | Duke University | Superoxide dismutase mimic |
| WO1992003052A1 (en) * | 1990-08-23 | 1992-03-05 | Jariwalla Raxit J | Method for suppression of hiv replication by ascorbate for chronic and acute hiv infection |
| FR2674753B1 (fr) * | 1991-04-02 | 1995-03-10 | Jean Berque | Nouvelles indications therapeutiques, en particulier pour le traitement du sida, d'un medicament deja existant et fabrique a partir d'une molecule denuee de contre-indications et d'effets indesirables. |
| US5281628A (en) * | 1991-10-04 | 1994-01-25 | American Cyanamid Company | 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines |
| US5460819A (en) * | 1991-12-13 | 1995-10-24 | Children's Medical Center Corporation | Method for treating PQQ-responsive heavy metal toxicity |
| JPH1165522A (ja) * | 1997-08-25 | 1999-03-09 | Mitsubishi Electric Corp | プラズマディスプレイパネルの駆動方法 |
-
1993
- 1993-05-28 AT AT93909698T patent/ATE271614T1/de not_active IP Right Cessation
- 1993-05-28 ES ES93909698T patent/ES2224098T3/es not_active Expired - Lifetime
- 1993-05-28 AU AU40545/93A patent/AU666372B2/en not_active Ceased
- 1993-05-28 DK DK93909698T patent/DK0643775T3/da active
- 1993-05-28 WO PCT/AU1993/000251 patent/WO1993024650A1/en not_active Ceased
- 1993-05-28 US US08/343,559 patent/US5981601A/en not_active Expired - Lifetime
- 1993-05-28 EP EP93909698A patent/EP0643775B1/de not_active Expired - Lifetime
- 1993-05-28 DE DE69333575T patent/DE69333575T2/de not_active Expired - Lifetime
- 1993-05-28 PT PT93909698T patent/PT643775E/pt unknown
- 1993-05-28 JP JP50002894A patent/JP3859699B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PT643775E (pt) | 2004-10-29 |
| AU666372B2 (en) | 1996-02-08 |
| EP0643775B1 (de) | 2004-07-21 |
| US5981601A (en) | 1999-11-09 |
| WO1993024650A1 (en) | 1993-12-09 |
| DE69333575T2 (de) | 2005-08-25 |
| EP0643775A4 (de) | 1995-12-27 |
| DE69333575D1 (de) | 2004-08-26 |
| ES2224098T3 (es) | 2005-03-01 |
| EP0643775A1 (de) | 1995-03-22 |
| JPH08500091A (ja) | 1996-01-09 |
| JP3859699B2 (ja) | 2006-12-20 |
| DK0643775T3 (da) | 2004-09-06 |
| AU4054593A (en) | 1993-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE271614T1 (de) | Quinone-derivate zur verbesserung der zellulare bioenergie | |
| FR2714830B1 (fr) | Composition contenant des acides nucléiques, préparation et utilisations. | |
| IL121126A0 (en) | Method of increasing expression of molecular chaperon by an eukarytic cell | |
| ATE84414T1 (de) | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus. | |
| EA199800943A1 (ru) | Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы | |
| TR200000481T2 (tr) | N-Alkonoilfenilalenin türevleri. | |
| TR200101539T2 (tr) | Serum glukoz ve trigliserid seviyelerini düşürme yöntemleri. | |
| ATE319440T1 (de) | Antidiabetische mittel | |
| ATE218868T1 (de) | Hustenhemmende, theobromine enthaltende zusammensetzungen | |
| MX9307509A (es) | Metodo y preparacion farmaceutica para reducir la actividad de las celulas. | |
| ATE84045T1 (de) | Hemmungsstoffe enkephalinase-b deren herstellung und deren pharmazeutische zusammensetzungen. | |
| ES2125887T3 (es) | Procedimiento ortomolecular para tratar la anemia drepanocitica. | |
| ATE330613T1 (de) | Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis | |
| KR950031085A (ko) | 표피증식 질환 치료용 의약 조성물 | |
| ATE39357T1 (de) | Derivate von griseolicsaeure und ihre verwendung. | |
| ES8407321A1 (es) | "un procedimiento para preparar un compuesto organico de selenio" | |
| GB1474424A (en) | Pharmaceutical composition for treating diabetic ketoacidosis | |
| ATE551058T1 (de) | Zusammensetzungen enthaltend tempamine und deren verwendung zum schutz vor oxidativer schädigung | |
| ATE232541T1 (de) | Gallensauersälze mit physiologisch aktiven metalle und ihre verwendung zur therapeutischen behandlung | |
| TH29868A (th) | วิธีการและองค์ประกอบของสารสำหรับทำให้สีของผิวหนังจางลง | |
| JPH07258024A (ja) | メラニン生成阻害剤 | |
| BG42833A3 (bg) | Метод за получаване на 1,3-бис/диметиламино/-2-пропил- 4-хлорфеноксиацетат | |
| UA32157A (uk) | Спосіб лікування діабетичної ретинопатії |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0643775 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |